GlassScriptPhysician profile
Rayeesa Ahmad
NPI 1841633708
$1,578.37
in general payments reported to CMS, 2019-2025
23 companies · $23.60 in 2025
The $23.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $406 · 2021: $454 · 2025: $23.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $239.42 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.70 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $168.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $100.52 | 2019-2021 | |
| Novo Nordisk INC | $83.15 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $75.09 | 2019-2025 | Invega Sustenna |
| Lilly USA, LLC | $74.07 | 2019-2021 | |
| Amarin Pharma, INC. | $71.69 | 2019-2021 | |
| Abbvie INC. | $70.19 | 2019-2021 | |
| Amgen INC. | $63.70 | 2019-2021 | |
| Allergan, INC. | $60.62 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $51.47 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $51.28 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $41.38 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.28 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.50 | 2019-2021 | |
| Astellas Pharma US INC | $31.32 | 2019-2021 | |
| Lifescan, INC. | $21.27 | 2019 | |
| Abbott Laboratories | $20.67 | 2019 | |
| Daiichi Sankyo INC. | $18.80 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.38 | 2020 | |
| Sunovion Pharmaceuticals INC. | $13.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rayeesa Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.